Pr Philippe Moreau
- Spécialité
- Hématologue, expert myélome multiple
- Hôpital
- Centre Hospitalier Universitaire de Nantes
- Derniers articles
-
- Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy. (1 août 2026)
- International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas. (22 juil. 2026)
- Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial. (3 juil. 2026)
- Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma. (2 juil. 2026)
- Idecabtagene vicleucel and endogenous T-cell phenotypes linked to progression-free survival in relapsed multiple myeloma. (2 juil. 2026)